Drug Type Immune stimulating antibody conjugate (ISAC) |
Synonyms- |
Target |
Mechanism HER2 modulators(Receptor protein-tyrosine kinase erbB-2 modulators), TLR8 modulators(Toll like receptor 8 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 10 Jun 2024 |